Introduction: Churg-Strauss syndrome (CSS) is a rare, systemic, necrotizing, small- and middle-sized vessel vasculitis which is accompanied by blood eosinophilia, eosinophil infiltration of various tissues and bronchial asthma. Leukotriene receptor antagonists (LTRAs) may participate in the pathogenesis of the disease.
Aim Of The Study: The aim of this study was a retrospective evaluation of the influence of LTRAs on the development of CSS and its later course.
Patients And Methods: Hospital charts of 24 patients from the southern Poland region with diagnosed CSS between 1999-2010 were retrospectively analyzed. Additional questionnaire concerning the LTRAs treatment was obtained from all patients. The diagnosis of the disease was reassessed and confirmed with the current guidelines.
Results: In the studied group, before the development of CSS, 16 patients (66.7%) used LTRAs--namely montelukast. The average time from the beginning of treatment to the development of CSS symptoms was 14 months. Tapering down corticosteroid treatment was not observed. Patients treated with montelukast at the time of diagnosis had higher blood eosinopilia (7254 vs 2105, p<0.05), and more common nasal polyposis (68.75% vs 12.5%, p<0.05) with a need for polipectomy (62.5% vs 0%, p<0.05) when compared to patients not receiving the drug. Also the course of the disease was more severe in the LTRAs treated patients: more common exacerbations (5.93 vs 1.62, p<0.01) with the need for hospitalizations (1.6 vs 0.36/year, p<0.001) and need for higher base corticosteroids doses (9.75 vs 5 mg, p<0.05) and additional immunosuppressive therapy (81.25% vs 50%, p>0.05) to maintain the disease remission.
Conclusions: Patients receiving LTRAs before diagnosis of CSS had more severe course of the disease. Prescribing LTRAs for patients with asthma accompanied by nasal polyposis, and high blood eosinophilia needs special precautions. Further studies on the influence of LTRAs on CSS are needed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The influence of genotype on the natural history of types 1 - 3 spinal muscular atrophy.
Neuromuscul Disord
December 2024
Pharma Personalized Healthcare, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
The severity of spinal muscular atrophy (SMA) is inversely correlated with the number of survival of motor neuron 2 (SMN2) copies an individual has. This observational, retrospective analysis of natural history data included untreated individuals with a genetic diagnosis of types 1-3 SMA and stratified disease-related characteristics by SMN2 copy number. The outcomes investigated were time to: death, permanent ventilation, respiratory support, feeding support, scoliosis surgery, and achievement and loss of motor milestones.
View Article and Find Full Text PDFCardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated Therapy.
Cancers (Basel)
January 2025
Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Milan, Italy.
Background: Radiotherapy for thymoma is delivered post-operatively in selected cases. Given the particular location of the thymic bed and the excellent prognosis, late cardiac toxicities may be an issue. The purpose of this retrospective dosimetric study is to investigate whether intensity-modulated proton beam therapy (IMPT) compared to photon therapy could better spare cardiac substructures, given prespecified dose constraints.
View Article and Find Full Text PDFMultiomic machine learning on lactylation for molecular typing and prognosis of lung adenocarcinoma.
Sci Rep
January 2025
Department of Respiratory Diseases, Qilu Hospital of Shandong University, No. 107, Culture West Road, Jinan, Shandong, China.
To integrate machine learning and multiomic data on lactylation-related genes (LRGs) for molecular typing and prognosis prediction in lung adenocarcinoma (LUAD). LRG mRNA and long non-coding RNA transcriptomes, epigenetic methylation data, and somatic mutation data from The Cancer Genome Atlas LUAD cohort were analyzed to identify lactylation cancer subtypes (CSs) using 10 multiomics ensemble clustering techniques. The findings were then validated using the GSE31210 and GSE13213 LUAD cohorts.
View Article and Find Full Text PDFEvaluating the Laboratory Performance of Pellet-Fueled Semigasifier Cookstoves.
Environ Sci Technol
January 2025
Air Methods and Characterization Division, U.S. Environmental Protection Agency, Office of Research and Development, 109 T.W. Alexander Drive, Research Triangle Park, North Carolina 27709, United States.
This study examines three representative semigasifier cookstove models each burning four types of pelletized-biomass fuel (hardwood, peanut hull, rice husk, and wheat straw) using the International Organization for Standardization (ISO) 19867-1:2018 protocol. ISO tier ratings for fine particulate matter (PM) and carbon monoxide (CO) emissions ranged 1-4 and 2-5 (where 5 = cleanest), respectively, suggesting that pellet-fueled cookstoves may provide substantial emissions reductions, dependent upon stove/fuel matching and operation, over other biomass-fueled cooking alternatives. PM emission factors based on useful energy delivered (EF) varied by up to 25-fold, and organic and elemental carbon (OC and EC) EF values respectively varied by >200- and ∼100-fold, reflecting complex variability in PM composition.
View Article and Find Full Text PDFThe choice of adjuvant radiotherapy in pancreatic cancer patients after up-front radical surgery.
PLoS One
January 2025
Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Background: The role of adjuvant radiotherapy in pancreatic cancer following radical surgery remains a subject of of controversy. This study aimed to more accurately screen pancreatic patients who benefit from adjuvant radiotherapy.
Methods: Clinicopathologic characteristics of patients with resectable pancreatic cancer were collected from the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!